Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global cancer registry software industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Delivery mode trends
2.1.5 Database trends
2.1.6 Functionality trends
2.1.7 End-user trends
Chapter 3 Cancer Registry Software Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Increasing government initiatives for cancer treatment
3.2.1.3 Growing adoption of HER
3.2.1.4 Increasing emphasis on evidence-based medicine
3.2.1.5 Demand for data-driven cancer care
3.2.2 Industry pitfalls & challenges
3.2.2.1 Data privacy and security related concerns
3.2.2.2 Limited awareness about cancer registry software in emerging markets
3.2.2.3 Data interoperability and standardization challenges
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By delivery mode
3.3.3 By database
3.3.4 By functionality
3.3.5 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Cancer Registry Software Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Standalone software
5.3 Integrated software
Chapter 6 Cancer Registry Software Market Size and Forecast, By Delivery Mode (USD Million)
6.1 Key trends, by delivery mode
6.2 On-premise
6.3 Cloud-based
Chapter 7 Cancer Registry Software Market Size and Forecast, By Database (USD Million)
7.1 Key trends, by database
7.2 Commercial databases
7.3 Public databases
Chapter 8 Cancer Registry Software Market Size and Forecast, By Functionality (USD Million)
8.1 Key trends, by functionality
8.2 Cancer reporting
8.3 Patient care management
8.4 Medical research and clinical studies
8.5 Product outcome evaluation
Chapter 9 Cancer Registry Software Market Size and Forecast, By End-User (USD Million)
9.1 Key trends, by end-user
9.2 Government organizations and third-party administration
9.3 Research institutes
9.4 Hospital & medical practices
9.5 Private payers
9.6 Pharmaceutical, biotech, and medical device companies
Chapter 10 Cancer Registry Software Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Elekta AB
11.2 C/NET Solutions
11.3 Electronic Registry Systems Inc.
11.4 Onco Inc.
11.5 McKesson Corporation
11.6 Siemens Healthineers
11.7 IBM Corporation
11.8 Ordinal data, Inc.
11.9 NeuralFrame, Inc
11.10 Conduent, Inc.
